A detailed history of Hardin Capital Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Hardin Capital Partners, LLC holds 9,923 shares of PFE stock, worth $265,341. This represents 0.16% of its overall portfolio holdings.

Number of Shares
9,923
Previous 9,100 9.04%
Holding current value
$265,341
Previous $255 Million 13.72%
% of portfolio
0.16%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$27.7 - $31.39 $22,797 - $25,833
823 Added 9.04%
9,923 $290 Million
Q2 2024

Aug 08, 2024

BUY
$25.26 - $29.6 $229,866 - $269,360
9,100 New
9,100 $255 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Hardin Capital Partners, LLC Portfolio

Follow Hardin Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hardin Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hardin Capital Partners, LLC with notifications on news.